Kerry Group (KRZ) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
19 Mar, 2026Who we are and market positioning
Global leader in integrated taste and nutrition ingredient solutions, enabling healthier, tastier, and more sustainable food and beverage products worldwide.
Operates at global scale with €7bn revenue, €1.2bn EBITDA, and a reach of 1.5bn consumers.
Employs 19,000 people across 119 facilities in 34 countries, with over 1,200 scientists and 100+ chefs and baristas.
Vision is to be the most valued partner for customers, creating a world of sustainable nutrition.
Growth strategy and differentiators
Focuses on sustainable nutrition, emerging markets, and foodservice as key growth drivers.
Consistently outperforms end markets, with high single-digit EPS growth and 3.8% average volume growth (2022–2025).
Maintains a diversified business across geographies, end-use markets, and technologies.
Strong presence and growth in emerging markets (7% volume CAGR) and foodservice (9% volume CAGR).
Technology and innovation
Offers a broad portfolio of taste and biotechnology solutions, including fermentation, modulation, and natural extracts.
Invested €3bn in science and technology since 2018, supporting 1,200+ patents and 60+ global innovation centres.
Proprietary tools like Kerry Kalaido® accelerate product ideation and market launch.
Delivers science-backed solutions for sugar, salt, and fat reduction, food preservation, and proactive health.
Latest events from Kerry Group
- Innovation, digital excellence, and disciplined growth drive strong financial and sustainability results.KRZ
Consumer Analyst Group of New York Conference (CAGNY) 202620 Feb 2026 - Strong volume and EPS growth, margin expansion, and innovation investments drive outlook.KRZ
Q4 202517 Feb 2026 - Upgraded EPS guidance, strong margin expansion, and robust T&N growth drive H1 outperformance.KRZ
Q2 20242 Feb 2026 - Q3 saw strong volume and margin growth, with full-year EPS guidance reaffirmed.KRZ
Q3 202418 Jan 2026 - Sale of Kerry Dairy Ireland for €500m will enhance margins, growth, and sustainability.KRZ
Investor Update15 Jan 2026 - Strong 2024 growth, margin expansion, and positive 2025 outlook after Dairy Ireland divestment.KRZ
Q4 20248 Jan 2026 - Targets high-single-digit EPS growth and 19-20% EBITDA margin by 2028, driven by innovation.KRZ
Consumer Analyst Group of New York Conference (CAGNY) 20258 Jan 2026 - Q1 2025 saw 3.1% volume growth, 90bps margin expansion, and EPS guidance maintained.KRZ
Q1 202525 Dec 2025 - 3.0% volume growth, 100bps margin expansion, and strong cash flow support full-year outlook.KRZ
Q2 20253 Nov 2025